On the recordMarch 4, 2013
A liability challenge. Generic drug makers defense faces a Supreme Court test.
Source
congress.govEditor's note · Context
Goodlatte refers to a legal case involving generic drug makers and its implications.
Share
More from Bob Goodlatte
Jul 18, 2022
The original intent being that which is held to be yours and reasonably expected to be for privacy must be returned to privacy.
Jul 18, 2022
Absolutely. Again, going back to the question that Mr. Issa had, the difference between the broader scope here and the narrower scope of this legislation is those entities, corporations, governments outside the United States, we should…
Jul 18, 2022
The principle of protecting people's rights under the Fourth Amendment has to come first.
Other voices in this conversation
